Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer

DISEASE CHARACTERISTICS: * Diagnosis of refractory or relapsed ovarian epithelial cancer * Must have failed prior regimen containing cisplatin or carboplatin * Bidimensionally measurable or evaluable disease * Serial CA-125 antigen titers or cytologically positive pleural effusion and/or ascites acceptable as evaluable disease * Autologous bone marrow harvest of greater than 1.2 x 10 to the eighth nucleated cells/kg required before study entry * No evidence of tumor at marrow harvest sites by bilateral bone marrow aspirates and biopsies, pelvic x-ray, and bone scan * CNS involvement allowed PATIENT CHARACTERISTICS: Age: * Under 65 Performance status: * SWOG 0-2 Life expectancy: * At least 8 weeks Hematopoietic: * WBC greater than 3,500/mm\^3 * Platelet count greater than 100,000/mm\^3 * Hemoglobin greater than 10.0 g/dL Hepatic: * Bilirubin less than 2.0 mg/dL * SGOT and SGPT less than 2 times upper limit of normal Renal: * Creatinine clearance greater than 60 mL/min * No prior hemorrhagic cystitis Cardiovascular: * LVEF greater than 45% by MUGA scan Other: * No hearing loss in voice tones * No active infection * No psychological contraindication to study treatment * Not pregnant * Negative pregnancy test * HIV negative * General medical condition must allow general anesthesia PRIOR CONCURRENT THERAPY: Biologic therapy: * See Disease Characteristics * No prior bone marrow transplantation * More than 4 weeks since other prior biologic therapy and recovered Chemotherapy: * See Disease Characteristics * More than 4 weeks since prior chemotherapy (at least 6 weeks for nitrosoureas or mitomycin) and recovered Endocrine therapy: * Not specified Radiotherapy: * More than 4 weeks since prior radiotherapy and recovered Surgery: * Not specified